Toggle Main Menu Toggle Search

Open Access padlockePrints

Ikaros family zinc finger 1 regulates dendritic cell development and function in humans

Lookup NU author(s): Dr Urszula Cytlak-ChaudhuriORCiD, Dr Anastasia ResteuORCiD, Dr Tom Altmann, Professor Andrew GenneryORCiD, Professor Graham Jackson, Professor Matthew CollinORCiD, Dr Venetia BigleyORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

Ikaros family zinc finger 1 (IKZF1) is a haematopoietic transcription factor required for mammalian B-cell development. IKZF1 deficiency also reduces plasmacytoid dendritic cell (pDC) numbers in mice, but its effects on human DC development are unknown. Here we show that heterozygous mutation of IKZF1 in human decreases pDC numbers and expands conventional DC1 (cDC1). Lenalidomide, a drug that induces proteosomal degradation of IKZF1, also decreases pDC numbers in vivo, and reduces the ratio of pDC/cDC1 differentiated from progenitor cells in vitro in a dose-dependent manner. In addition, non-classical monocytes are reduced by IKZF1 deficiency in vivo. DC and monocytes from patients with IKZF1 deficiency or lenalidomide-treated cultures secrete less IFN-α, TNF and IL-12. These results indicate that human DC development and function are regulated by IKZF1, providing further insights into the consequences of IKZF1 mutation on immune function and the mechanism of immunomodulation by lenalidomide.


Publication metadata

Author(s): Cytlak U, Resteu A, Bogaert D, Kuehn HS, Altmann T, Gennery A, Jackson G, Kumanovics A, Voelkerding KV, Prader S, Dullaers M, Reichenbach J, Hill H, Haerynck F, Rosenzweig SD, Collin M, Bigley V

Publication type: Article

Publication status: Published

Journal: Nature Communications

Year: 2018

Volume: 9

Online publication date: 27/03/2018

Acceptance date: 10/01/2018

Date deposited: 27/03/2018

ISSN (electronic): 2041-1723

Publisher: Nature Publishing Group

URL: https://doi.org/10.1038/s41467-018-02977-8

DOI: 10.1038/s41467-018-02977-8


Altmetrics


Funding

Funder referenceFunder name
101155/Z/13/ZWellcome Trust
AI094004
AI113631
CELL-PID
CGDS16/01
EU-FP7 NET4CGD
EU-FP7
HALTH-2010-261387

Share